⌘K

Login Start Free

Home/Filings/4/0001708138-21-000094

4//SEC Filing

VAGELOS P ROY 4

Accession 0001708138-21-000094

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 5:35 PM ET

Size

10.6 KB

Accession

0001708138-21-000094

Insider Transaction Report

Form 4

Period: 2021-12-08

REGENERON PHARMACEUTICALS, INC.REGN

Director

Transactions

Gift
Common Stock
2021-10-04−347→ 141,630 total(indirect: by CLAT)
Award
Non-Qualified Stock Option (right to buy)
2021-12-08+21,198→ 21,198 total
Exercise: $644.54Exp: 2031-12-08→ Common Stock (21,198 underlying)
Award
Common Stock
2021-12-08+1,861→ 318,669 total

Holdings

Common Stock
(indirect: By Trust)
37,747
Common Stock
(indirect: By Trust)
3,609
Common Stock
(indirect: By 401(k))
2,221

Footnotes (3)

[F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
[F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
[F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

IncorporatedMD

Related Parties

1

filerCIK 0001013064

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 5:35 PM ET
Size: 10.6 KB

View on SEC.gov